Get Premium to unlock powerful stock data

Tang Capital Management Llc Buys ANI Pharmaceuticals Inc, Allakos Inc, Immunogen Inc, Sells Aptevo Therapeutics Inc, NextCure Inc, Relmada Therapeutics Inc

Author's Avatar
Feb 18, 2022
Article's Main Image
San Diego, CA, based Investment company Tang Capital Management Llc (Current Portfolio) buys ANI Pharmaceuticals Inc, Allakos Inc, Immunogen Inc, BELLUS Health Inc, Legend Biotech Corp, sells Aptevo Therapeutics Inc, NextCure Inc, Relmada Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Tang Capital Management Llc. As of 2021Q4, Tang Capital Management Llc owns 29 stocks with a total value of $497 million. These are the details of the buys and sells.

For the details of TANG CAPITAL MANAGEMENT LLC's stock buys and sells, go to https://www.gurufocus.com/guru/tang+capital+management+llc/current-portfolio/portfolio

These are the top 5 holdings of TANG CAPITAL MANAGEMENT LLC
  1. AnaptysBio Inc (ANAB) - 2,628,678 shares, 18.37% of the total portfolio.
  2. Heron Therapeutics Inc (HRTX) - 7,782,928 shares, 14.29% of the total portfolio. Shares reduced by 1.57%
  3. Rocket Pharmaceuticals Inc (RCKT) - 2,531,800 shares, 11.12% of the total portfolio.
  4. La Jolla Pharmaceutical Co (LJPC) - 9,607,934 shares, 8.99% of the total portfolio. Shares reduced by 4.39%
  5. ITeos Therapeutics Inc (ITOS) - 937,500 shares, 8.78% of the total portfolio. Shares added by 4.17%
New Purchase: ANI Pharmaceuticals Inc (ANIP)

Tang Capital Management Llc initiated holding in ANI Pharmaceuticals Inc. The purchase prices were between $32.97 and $56.85, with an estimated average price of $43.22. The stock is now traded at around $38.280000. The impact to a portfolio due to this purchase was 2.78%. The holding were 300,000 shares as of 2021-12-31.

New Purchase: Allakos Inc (ALLK)

Tang Capital Management Llc initiated holding in Allakos Inc. The purchase prices were between $8.55 and $111.89, with an estimated average price of $80.43. The stock is now traded at around $5.980000. The impact to a portfolio due to this purchase was 2.61%. The holding were 1,323,393 shares as of 2021-12-31.

New Purchase: Immunogen Inc (IMGN)

Tang Capital Management Llc initiated holding in Immunogen Inc. The purchase prices were between $4.75 and $7.5, with an estimated average price of $6.22. The stock is now traded at around $5.340000. The impact to a portfolio due to this purchase was 2.24%. The holding were 1,500,000 shares as of 2021-12-31.

New Purchase: BELLUS Health Inc (BLU)

Tang Capital Management Llc initiated holding in BELLUS Health Inc. The purchase prices were between $5.26 and $8.3, with an estimated average price of $6.65. The stock is now traded at around $7.140000. The impact to a portfolio due to this purchase was 1.94%. The holding were 1,200,000 shares as of 2021-12-31.

New Purchase: Legend Biotech Corp (LEGN)

Tang Capital Management Llc initiated holding in Legend Biotech Corp. The purchase prices were between $41.14 and $56.98, with an estimated average price of $50.77. The stock is now traded at around $38.550000. The impact to a portfolio due to this purchase was 1.87%. The holding were 200,000 shares as of 2021-12-31.

New Purchase: BioAtla Inc (BCAB)

Tang Capital Management Llc initiated holding in BioAtla Inc. The purchase prices were between $19 and $30.95, with an estimated average price of $25.42. The stock is now traded at around $6.610000. The impact to a portfolio due to this purchase was 1.18%. The holding were 297,914 shares as of 2021-12-31.

Added: ASLAN Pharmaceuticals Ltd (ASLN)

Tang Capital Management Llc added to a holding in ASLAN Pharmaceuticals Ltd by 110.70%. The purchase prices were between $1.11 and $1.86, with an estimated average price of $1.49. The stock is now traded at around $0.950200. The impact to a portfolio due to this purchase was 0.24%. The holding were 2,054,925 shares as of 2021-12-31.

Sold Out: Aptevo Therapeutics Inc (APVO)

Tang Capital Management Llc sold out a holding in Aptevo Therapeutics Inc. The sale prices were between $6.48 and $17.49, with an estimated average price of $11.58.

Sold Out: NextCure Inc (NXTC)

Tang Capital Management Llc sold out a holding in NextCure Inc. The sale prices were between $5.7 and $9.1, with an estimated average price of $6.94.



Here is the complete portfolio of TANG CAPITAL MANAGEMENT LLC. Also check out:

1. TANG CAPITAL MANAGEMENT LLC's Undervalued Stocks
2. TANG CAPITAL MANAGEMENT LLC's Top Growth Companies, and
3. TANG CAPITAL MANAGEMENT LLC's High Yield stocks
4. Stocks that TANG CAPITAL MANAGEMENT LLC keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles